Quantcast

Latest Genome engineering Stories

2014-10-01 08:33:08

CAMBRIDGE, Mass., Oct. 1, 2014 /PRNewswire/ -- Celexion, a bioengineering company developing powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and life science research sectors, today announced that the United States Patent and Trademark Office (USPTO) has recently granted three U.S. patents to the company, bringing the total U.S. patents issued to Celexion to eight. These patents relate to metabolic engineering and the...

2014-07-30 23:05:41

Data addresses key issues associated with effective translation, translocation and secretion of therapeutic proteins in mammalian cell lines Geneva, Switzerland (PRWEB) July 30, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development, announced today new data from the Company’s SURE CHO-Mplus Libraries™ will be presented at the 10th Annual Cell Line Development and Engineering conference being held,...

2014-07-07 12:28:43

CRISPR/Cas9 system allows researchers to quickly and precisely edit DNA ST. LOUIS, July 7, 2014 /PRNewswire/ -- SAGE Labs Inc., a leading provider of in vivo products, services and technologies in the field of genome engineering, today launched its SAGEspeed CRISPR/Cas9 Reagents. These reagents enable researchers to quickly and easily perform genetic engineering in animal models, such as mice and rats, as well as cell lines. Since 2009, SAGE Labs has been using targeted nucleases,...

2014-05-30 23:06:45

Dr. Igor Fisch to Present Data on Using Genome Engineering and the Selexis SURE CHO-Mplus Libraries for Optimal Transgene Expression and Recombinant Protein Production Geneva, Switzerland (PRWEB) May 30, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development announced today the Company’s CEO, Igor Fisch, Ph.D., will present “Genome Engineering and SURE CHO-Mplus Libraries™ for Optimal Transgene Expression...

2014-05-27 12:32:48

PARIS, May 27, 2014 /PRNewswire/ -- Andre Choulika, PhD, CEO of Cellectis (Alternext: ALCLS) and Mathieu Simon, MD, Executive Vice President will be attending this year's ASCO meeting in Chicago, IL on May the 30th to June 3rd, 2014. Disruptive innovation in oncology by gene editing and T cell CARs Cellectis is developing innovative cancer products based on engineered T cells armed with a Chimeric Antigen Receptor (CAR) to target liquid and solid tumors....

2014-05-14 23:02:07

The new NextGEN™ CRISPR genome engineering tools and services provided by Transposagen are ideal when research and drug discovery applications require clean, high-precision genome editing. Lexington, KY (PRWEB) May 14, 2014 Altering the genome with targeted nucleases is powerful and increasingly necessary for research and drug discovery. The CRISPR-Cas9 system has gained popularity due to its simplicity and high efficiency. While the original CRISPR technology is not owned or...

2014-05-11 00:21:06

The NextGEN(TM) CRISPR genome engineering tools and services provided by Transposagen are ideal when research and drug discovery applications require clean, high-precision genome editing. LEXINGTON, Ky., May 11, 2014 /PRNewswire-iReach/ -- Altering the genome with targeted nucleases is powerful and increasingly necessary for research and drug discovery. The CRISPR-Cas9 system has gained popularity due to its simplicity and high efficiency. While the original CRISPR technology is not...

2014-05-06 08:33:26

Innovative paired-nickase design provides breakthrough that minimizes off-target effects to accelerate genetic research ST. LOUIS, May 6, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced the availability of high-fidelity Sigma(®) CRISPR paired nickases, a novel patent-pending gene editing tool that can be easily and inexpensively employed in academic, agricultural, pharmaceutical, human health and other applications. The high-fidelity CRISPR technology...

2014-04-28 10:17:33

A next-generation genome editing system developed by Massachusetts General Hospital (MGH) investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites. "This system combines the ease of use of the widely...

2014-03-10 12:26:10

Corn Traits for Improved Dairy and Beef Nutrition RESEARCH TRIANGLE PARK, N.C. and MEDFORD, Mass., March 10, 2014 /PRNewswire/ -- Precision BioSciences and Agrivida revealed today that they have entered into a trait development collaboration based on precise gene modifications made possible by Precision's Directed Nuclease Editor(TM) (DNE) Technology. The collaboration recently delivered the first modified genes that are the subject of Agrivida commercialization efforts in the area...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related